COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.

ABSTRACT:

Background

It is reasonable to think that cancer patients undergoing chemotherapy, targeted therapy or immunotherapy could have a more aggressive course if positive for Coronavirus disease CoV-2 (COVID- 19).

Methods

We conducted a literature review on https://www.ncbi.nlm.nih.gov/pubmed/, https://scholar.google.com, www.arxiv.org, www.biorxiv.org, of all articles published using the keywords COVID-19 therapy or treatment and cancer until May 2, 2020. A total of 205 articles were identified and 53 were included in this review.

Results

We describe the ongoing COVID-19 therapies that should be known by oncologists and highlight the potential interactions with antineoplastic drugs, commonly used in clinical practice. The main drug interactions were found with tocilizumab,

SUBMITTER: Di Lorenzo G 

PROVIDER: S-EPMC7239789 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature